Literature DB >> 17330687

Why and how to use insulin therapy earlier in the management of type 2 diabetes.

Luigi Meneghini1.   

Abstract

Most patients with type 2 diabetes are inadequately controlled on their current therapy. Suboptimal glycemic control can have devastating consequences, such as retinopathy, nephropathy, neuropathy, and cardiovascular disease that may ultimately lead to mortality. Most patients eventually need insulin therapy, and initiating insulin earlier in the course of type 2 diabetes may lead to optimal glycemic control and prevent or delay diabetes-related complications. Although insulin therapy is the most effective method of managing hyperglycemia, it is often delayed owing to concerns about the complexity and inconvenience of treatment regimens; fear of injections, hypoglycemia or weight gain; and the time required to learn how to effectively manage insulin therapy. The development of insulin analogs, biphasic insulin analogs, and more convenient insulin delivery systems may make insulin therapy more manageable and help more patients achieve their treatment goals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17330687     DOI: 10.1097/SMJ.0b013e31802ed2ea

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

Review 1.  Antidiabetic medications and weight gain: implications for the practicing physician.

Authors:  Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

Review 2.  Identifying and meeting the challenges of insulin therapy in type 2 diabetes.

Authors:  Christopher Sorli; Michael K Heile
Journal:  J Multidiscip Healthc       Date:  2014-07-02

3.  Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities.

Authors:  Meryl Brod; Suzanne Lessard Alolga; Luigi Meneghini
Journal:  Patient       Date:  2014       Impact factor: 3.883

4.  Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia.

Authors:  Nebojša Lalić; Monika Russel-Szymczyk; Marina Culic; Christian Klyver Tikkanen; Barrie Chubb
Journal:  Diabetes Ther       Date:  2018-04-26       Impact factor: 2.945

Review 5.  Insulin therapy and type 2 diabetes: management of weight gain.

Authors:  Samy I McFarlane
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-10       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.